Ketek Copy-Cat Drug Marketed in Asia

A drug similar to Ketek, which is an antibiotic that has been linked to liver disease among patients, is getting ready to be sold in Asia even after red flags were raised on these drugs.

Ketek is part of the class of drugs known as ketolide belonging to the macrolide group. The ketolide antibiotics are a new group of drugs that are used to treat respiratory infections. The only ketolide drug available for manufacture is Ketek but because of dangerous levels of toxicity the U.S. Food and Drug Administration (FDA) have issued increased regulations for the drug.

The drug, which is manufactured by Advanced Life Sciences and marketed Wyeth, is continuing to be produced even though the drug could potentially contain side effects similar to Ketek.

First available in mid-2004 Ketek, telithromycin, from Sanofi-Aventis was developed for the following treatments, according to the FDA:

* community-acquired pneumonia

* multi-drug resistant Streptococcus pneumoniae

* acute bacterial sinusitis

* acute bacterial exacerbation of chronic bronchitis

What Are The Ketek Risks?

In early 2006, an issue of the Annals of Internal Medicine reported the link between Ketek and the development of life-threatening liver toxicity among patients. A warning has been issued by the FDA on the dangers of Ketek, which is under investigation. It is important for patients to look for the following risks:

* yellowing of skin/eyes

* vision loss/blurry vision

* fainting

* abdominal cramps

In addition to developing liver damage or liver toxicity, patients are also at risk for developing pseudomembrane colitis, which is an intestine infection, as well as hosting a lengthy list of side effects such as:

* watery diarrhea

* continued diarrhea

* blood stool

* stomach cramps

* nausea

* headache

* dizziness

* vomiting

* loose stools

* skin rash

* fatigue

* pain, upper abdominal and abdominal

* dry mouth

* insomnia

* vertigo

Unfortunately the list of side effects continues, and all were found during Phase III clinical trials of the drug in which 4,780 patients were tested for the drug's side effects and treatment effectiveness.

Overcoming the Ketek Risks

While the FDA continues to investigate the approximately 12 cases of acute liver failure, four fatalities and 20 cases of liver damage among patients, the drug remains on the market. Patients continue to be exposed to the potential Ketek risks of developing liver failure and liver toxicity.

Patients consuming Ketek are encouraged to contact their general physician to discuss the potential Ketek side effects. Additionally, if a patient has suffered from the Ketek dangers they are advised to consult a legal professional, particularly an experienced pharmaceutical attorney who can provide a legal consultation as to the potential need for creating a Ketek class action. Because liver damage can gravely effect an individual's life it is important that the appropriate justice is sought and, this may result in monetary compensation for a Ketek victim.


------

LegalView (http://www.LegalView.com) offers an array of legal issues ranging from Ketek class actions (http://www.ketek-legal-help.com) to the latest on TBI jury verdicts or how to develop an Avandia lawsuit.